Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Korro Bio (KRRO) Shares Outstanding (2019 - 2025)

Korro Bio's Shares Outstanding history spans 7 years, with the latest figure at $9.4 million for Q4 2025.

  • For the quarter ending Q4 2025, Shares Outstanding changed 0.43% year-over-year to $9.4 million, compared with a TTM value of $9.4 million through Dec 2025, changed 0.43%, and an annual FY2025 reading of $9.4 million, changed 0.43% over the prior year.
  • Shares Outstanding for Q4 2025 was $9.4 million at Korro Bio, roughly flat from $9.4 million in the prior quarter.
  • The five-year high for Shares Outstanding was $35.3 million in Q3 2022, with the low at $237803.0 in Q4 2021.
  • Average Shares Outstanding over 5 years is $14.6 million, with a median of $9.4 million recorded in 2024.
  • Year-over-year, Shares Outstanding crashed 99.3% in 2021 and then soared 3209.12% in 2024.
  • Tracing KRRO's Shares Outstanding over 5 years: stood at $237803.0 in 2021, then rose by 12.87% to $268399.0 in 2022, then surged by 2886.79% to $8.0 million in 2023, then rose by 16.97% to $9.4 million in 2024, then rose by 0.43% to $9.4 million in 2025.
  • Per Business Quant, the three most recent readings for KRRO's Shares Outstanding are $9.4 million (Q4 2025), $9.4 million (Q3 2025), and $9.4 million (Q2 2025).